InvestorsHub Logo

JJM760

07/14/10 7:32 PM

#886 RE: BTH #884

$15 seems reasonable. Would the Harvster let her go for a measly $1.6 bil? My opinion is that Mrk is obviously our best suitor. A 534 collaboration with another pharma might cloud things a bit.